251 related articles for article (PubMed ID: 15853175)
1. Current and emerging options in the management of venous thromboembolism.
Jaffer AK; Brotman DJ; Michota F
Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S14-23. PubMed ID: 15853175
[TBL] [Abstract][Full Text] [Related]
2. Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.
Nutescu EA
Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S5-13. PubMed ID: 17519445
[TBL] [Abstract][Full Text] [Related]
3. Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism.
Bauer KA; Eriksson BI; Lassen MR; Turpie AG
Curr Opin Pulm Med; 2002 Sep; 8(5):398-404. PubMed ID: 12172443
[TBL] [Abstract][Full Text] [Related]
4. Evolving concepts in the treatment of venous thromboembolism: the role of factor Xa inhibitors.
Nutescu EA; Helgason CM
Pharmacotherapy; 2004 Jul; 24(7 Pt 2):82S-87S. PubMed ID: 15317403
[TBL] [Abstract][Full Text] [Related]
5. Current perspectives on the treatment of venous thromboembolism: need for effective, safe and convenient new antithrombotic drugs.
O'Shaughnessy DF
Int J Clin Pract; 2004 Mar; 58(3):277-84. PubMed ID: 15117096
[TBL] [Abstract][Full Text] [Related]
6. Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
Davidson BL; Büller HR; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob GE; Segers AE; Lensing AW;
J Thromb Haemost; 2007 Jun; 5(6):1191-4. PubMed ID: 17403087
[TBL] [Abstract][Full Text] [Related]
7. Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism.
Robinson DM; Wellington K
Am J Cardiovasc Drugs; 2005; 5(5):335-46. PubMed ID: 16156690
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism and pregnancy.
Andres RL; Miles A
Obstet Gynecol Clin North Am; 2001 Sep; 28(3):613-30. PubMed ID: 11512505
[TBL] [Abstract][Full Text] [Related]
9. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
10. [Current status of the management of venous thromboembolism in Japan].
Nakamura M
Nihon Rinsho; 2014 Jul; 72(7):1298-302. PubMed ID: 25163325
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparins in the long-term treatment of venous thromboembolism.
Liapis CD; Daskalopoulos ME; Daskalopoulou SE
J Cardiovasc Surg (Torino); 2002 Aug; 43(4):495-500. PubMed ID: 12124561
[TBL] [Abstract][Full Text] [Related]
12. Advances in the management of venous thromboembolism.
Schulman S
Best Pract Res Clin Haematol; 2012 Sep; 25(3):361-77. PubMed ID: 22959552
[TBL] [Abstract][Full Text] [Related]
13. Emerging options in the treatment of venous thromboembolism.
Nutescu EA
Am J Health Syst Pharm; 2004 Dec; 61(23 Suppl 7):S12-7. PubMed ID: 15597574
[TBL] [Abstract][Full Text] [Related]
14. Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis.
Thachil J
Ann Pharmacother; 2014 Mar; 48(3):420-4. PubMed ID: 24473488
[TBL] [Abstract][Full Text] [Related]
15. [Natural and synthetic glycosaminoglycans. Molecular characteristics as the basis of distinct drug profiles].
Alban S
Hamostaseologie; 2008 Feb; 28(1-2):51-61. PubMed ID: 18278163
[TBL] [Abstract][Full Text] [Related]
16. Emerging anticoagulants for the treatment of venous thromboembolism.
Weitz JI
Thromb Haemost; 2006 Sep; 96(3):274-84. PubMed ID: 16953267
[TBL] [Abstract][Full Text] [Related]
17. Current management of venous thromboembolism in Japan: Current epidemiology and advances in anticoagulant therapy.
Nakamura M; Yamada N; Ito M
J Cardiol; 2015 Dec; 66(6):451-9. PubMed ID: 25896176
[TBL] [Abstract][Full Text] [Related]
18. [New anticoagulants in the treatment of venous thrombo-embolic disease].
Bura-Riviere A; Fiessinger JN
Rev Med Interne; 2003 Nov; 24(11):738-44. PubMed ID: 14604751
[TBL] [Abstract][Full Text] [Related]
19. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
Huisman MV; Bounameaux H
Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
[TBL] [Abstract][Full Text] [Related]
20. Novel anticoagulants for the prevention and treatment of venous thromboembolism.
Weltermann A; Kyrle PA; Eichinger S
Wien Med Wochenschr; 2003; 153(19-20):426-33. PubMed ID: 14648923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
